The call will be simultaneously broadcast live over the Internet on vcall.com at http://www.investorcalendar.com/IC/CEPage.asp?ID=138525. A replay of the webcast will be available on Vcall for 30 days.
For further information, visit the Cantel website at www.cantelmedical.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.
CANTEL MEDICAL CORP.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share data)
Three Months Ended
October 31,
-----------
2008 2007
---- ----
Net sales $64,406 $60,005
Cost of sales 40,783 38,799
------ ------
Gross profit 23,623 21,206
Expenses:
Selling 7,350 6,789
General and administrative 9,024 8,957
Research and development 1,065 990
'/>"/>
| SOURCE Cantel Medical Corp. Copyright©2008 PR Newswire. All rights reserved |